GleamWall
中文EN

GMED GLOBUS MEDICAL INC

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 1237831 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY13.4%
TTM net income YoY31.6%
TTM EPS YoY31.4%
Revenue 3-yr CAGR36.8%
Net income 3-yr CAGR52.3%

Margins

Gross margin69.1%
Operating margin21.6%
Net margin17.8%
FCF margin24.4%
EBITDA margin28.7%

Returns

ROE12.1%
ROA10.5%
ROIC (approx.)12.9%
Asset turnover0.59x

Leverage & solvency

Liabilities / assets13.2%
Debt / equity0.00x
Current ratio4.30x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.66x
Accruals ratio-6.9%
Payout ratio—
Capex / revenue5.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$2.94B$2.52B
Cost of revenue$957.80M$1.04B
Gross profit$1.98B$1.48B
R&D expense$147.25M$163.75M
SG&A expense$1.18B$981.36M
Operating income$479.82M$165.99M
Pretax income$605.07M$120.72M
Income tax$67.20M$17.74M
Net income$537.87M$102.98M
EBITDA$756.66M$419.38M
EPS (basic)3.980.76
EPS (diluted)3.920.75
Weighted avg. shares (diluted)137.06M137.86M
Banking
Net interest income—-$4.19M
Balance sheet
Cash & equivalents$526.16M$784.44M
Short-term investments$31.09M$105.62M
Receivables$678.94M$557.70M
Inventory$759.28M$659.23M
Current assets$2.13B$2.18B
PP&E, net$564.45M$561.91M
Goodwill$1.44B$1.43B
Intangibles$745.06M$795.12M
Total assets$5.30B$5.25B
Current liabilities$498.50M$855.91M
Total liabilities$729.51M$1.07B
Shareholders' equity$4.57B$4.18B
Cash flow statement
Operating cash flow$753.45M$520.64M
Capital expenditure$164.68M$115.43M
Free cash flow$588.77M$405.21M
Investing cash flow-$355.01M-$176.05M
Financing cash flow-$679.16M-$27.70M
Depreciation & amortization$276.84M$253.39M
Stock-based compensation$49.78M$54.19M
Share buybacks$300.45M$85.79M

Free plan shows the latest 2 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.